IMVT
Immunovant Inc

2,192
Mkt Cap
$4.35B
Volume
3.72M
52W High
$28.08
52W Low
$12.72
PE Ratio
-9.34
IMVT Fundamentals
Price
$26.42
Prev Close
$24.81
Open
$24.90
50D MA
$21.56
Beta
0.99
Avg. Volume
1.43M
EPS (Annual)
-$2.73
P/B
8.87
Rev/Employee
$0.00
Loading...
Loading...
News
all
press releases
Immunovant (NASDAQ:IMVT) Stock Price Up 8.1% - Still a Buy?
Immunovant (NASDAQ:IMVT) Stock Price Up 8.1% - Here's What Happened...
MarketBeat·14h ago
News Placeholder
More News
News Placeholder
Immunovant (NASDAQ:IMVT) Stock Price Up 8.1% - Here's Why
Immunovant (NASDAQ:IMVT) Trading Up 8.1% - Still a Buy...
MarketBeat·14h ago
News Placeholder
Immunovant, Inc. $IMVT is Armistice Capital LLC's 9th Largest Position
Armistice Capital LLC lowered its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 3.7% during the 2nd quarter, according to the company in its most recent filing with the SEC. The...
MarketBeat·1d ago
News Placeholder
HighVista Strategies LLC Buys 87,160 Shares of Immunovant, Inc. $IMVT
HighVista Strategies LLC increased its stake in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 91.1% during the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·2d ago
News Placeholder
Immunovant (IMVT) Down 0.6% Since Last Earnings Report: Can It Rebound?
Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Zacks·3d ago
News Placeholder
Norges Bank Buys Shares of 687,662 Immunovant, Inc. $IMVT
Norges Bank purchased a new position in shares of Immunovant, Inc. (NASDAQ:IMVT - Free Report) during the second quarter, according to its most recent filing with the Securities and Exchange...
MarketBeat·3d ago
News Placeholder
Two Seas Capital LP Boosts Stake in Immunovant, Inc. $IMVT
Two Seas Capital LP lifted its position in Immunovant, Inc. (NASDAQ:IMVT - Free Report) by 37.1% in the 2nd quarter, according to its most recent 13F filing with the SEC. The institutional investor...
MarketBeat·8d ago
News Placeholder
Insider Selling: Immunovant (NASDAQ:IMVT) Director Sells 15,000 Shares of Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) Director Douglas Hughes sold 15,000 shares of the firm's stock in a transaction on Monday, December 1st. The stock was sold at an average price of...
MarketBeat·8d ago
News Placeholder
Insider Selling: Immunovant (NASDAQ:IMVT) Director Sells 22,249 Shares of Stock
Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) Director Andrew Fromkin sold 22,249 shares of the business's stock in a transaction on Monday, December 1st. The stock was sold at an average price of...
MarketBeat·9d ago
News Placeholder
Immunovant, Inc. (NASDAQ:IMVT) Given Consensus Recommendation of "Moderate Buy" by Analysts
Shares of Immunovant, Inc. (NASDAQ:IMVT - Get Free Report) have received a consensus recommendation of "Moderate Buy" from the twelve ratings firms that are covering the stock, Marketbeat.com...
MarketBeat·9d ago

Latest IMVT News

View

Advertisement|Remove ads.

Advertisement|Remove ads.